134 related articles for article (PubMed ID: 18226133)
1. Effects of hormone replacement therapy on bone mineral density in Turkish patients with or without COL1A1 Sp1 binding site polymorphism.
Simsek M; Cetin Z; Bilgen T; Taskin O; Luleci G; Keser I
J Obstet Gynaecol Res; 2008 Feb; 34(1):73-7. PubMed ID: 18226133
[TBL] [Abstract][Full Text] [Related]
2. COL1A1 Sp1 polymorphism predicts perimenopausal and early postmenopausal spinal bone loss.
MacDonald HM; McGuigan FA; New SA; Campbell MK; Golden MH; Ralston SH; Reid DM
J Bone Miner Res; 2001 Sep; 16(9):1634-41. PubMed ID: 11547832
[TBL] [Abstract][Full Text] [Related]
3. Combined effects of collagen type I alpha1 (COL1A1) Sp1 polymorphism and osteoporosis risk factors on bone mineral density in Turkish postmenopausal women.
Kurt-Sirin O; Yilmaz-Aydogan H; Uyar M; Seyhan MF; Isbir T; Can A
Gene; 2014 May; 540(2):226-31. PubMed ID: 24566004
[TBL] [Abstract][Full Text] [Related]
4. Association of estrogen receptor alpha and collagen type I alpha 1 gene polymorphisms with bone mineral density in postmenopausal women.
Erdogan MO; Yıldız H; Artan S; Solak M; Taşcıoğlu F; Dündar U; Eser B; Colak E
Osteoporos Int; 2011 Apr; 22(4):1219-25. PubMed ID: 20532479
[TBL] [Abstract][Full Text] [Related]
5. Collagen type 1 (COL1A1) Sp1 binding site polymorphism is associated with osteoporotic fractures but not with bone density in post-menopausal women from the Canary Islands: a preliminary study.
Navarro MC; Sosa M; del Pino-Montes J; Torres A; Salido E; Saavedra P; Corral-Gudino L; Montilla CA
Aging Clin Exp Res; 2007 Feb; 19(1):4-9. PubMed ID: 17332715
[TBL] [Abstract][Full Text] [Related]
6. Association of the type I collagen alpha1 Sp1 polymorphism, bone density and upper limb muscle strength in community-dwelling elderly men.
Van Pottelbergh I; Goemaere S; Nuytinck L; De Paepe A; Kaufman JM
Osteoporos Int; 2001; 12(10):895-901. PubMed ID: 11716195
[TBL] [Abstract][Full Text] [Related]
7. Meta-analysis of COL1A1 Sp1 polymorphism in relation to bone mineral density and osteoporotic fracture.
Mann V; Ralston SH
Bone; 2003 Jun; 32(6):711-7. PubMed ID: 12810179
[TBL] [Abstract][Full Text] [Related]
8. An SP1-binding site polymorphism in the COLIAI gene and osteoporosis in Egyptian patients with thalassemia major.
Hamed HM; Galal A; Ghamrawy ME; Abd El Azeem K; Hussein IR; Abd-Elgawad MF
Blood Coagul Fibrinolysis; 2011 Mar; 22(2):81-5. PubMed ID: 21178584
[TBL] [Abstract][Full Text] [Related]
9. Relation of JAGGED 1 and collagen type 1 alpha 1 polymorphisms with bone mineral density in Chinese postmenopausal women.
Zhang LQ; Liu H; Huang XF
Int J Clin Exp Pathol; 2014; 7(10):7142-7. PubMed ID: 25400810
[TBL] [Abstract][Full Text] [Related]
10. COLIA1 Sp1 polymorphism predicts response of femoral neck bone density to cyclical etidronate therapy.
Qureshi AM; Herd RJ; Blake GM; Fogelman I; Ralston SH
Calcif Tissue Int; 2002 Mar; 70(3):158-63. PubMed ID: 11907712
[TBL] [Abstract][Full Text] [Related]
11. The Sp1 COLIA1 gene polymorphism, and not vitamin D receptor or estrogen receptor gene polymorphisms, determines bone mineral density in postmenopausal Greek women.
Efstathiadou Z; Kranas V; Ioannidis JP; Georgiou I; Tsatsoulis A
Osteoporos Int; 2001; 12(4):326-31. PubMed ID: 11420783
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms of collagen 1A1 (COL1A1) gene and their relation to bone mineral density in postmenopausal women.
Majchrzycki M; Bartkowiak-Wieczorek J; Wolski H; Drews K; Bogacz A; Czerny B; Zagrodnik-Ułan E; Seremak-Mrozikiewicz A
Ginekol Pol; 2015 Dec; 86(12):907-14. PubMed ID: 26995940
[TBL] [Abstract][Full Text] [Related]
13. Lack of influence of collagen type Ialpha1 Sp1 binding site polymorphism on the rate of bone loss in a cohort of postmenopausal danish women followed for 18 years.
Heegaard A; Jorgensen HL; Vestergaard AW; Hassager C; Ralston SH
Calcif Tissue Int; 2000 Jun; 66(6):409-13. PubMed ID: 10821875
[TBL] [Abstract][Full Text] [Related]
14. Association of the collagen type 1 (COL1A 1) Sp1 binding site polymorphism to femoral neck bone mineral density and wrist fracture in 1044 elderly Swedish women.
Gerdhem P; Brändström H; Stiger F; Obrant K; Melhus H; Ljunggren O; Kindmark A; Akesson K
Calcif Tissue Int; 2004 Mar; 74(3):264-9. PubMed ID: 14595528
[TBL] [Abstract][Full Text] [Related]
15. Polymorphism at an Sp1 binding site of COL1A1 and bone mineral density in premenopausal female twins and elderly fracture patients.
Hustmyer FG; Liu G; Johnston CC; Christian J; Peacock M
Osteoporos Int; 1999; 9(4):346-50. PubMed ID: 10550452
[TBL] [Abstract][Full Text] [Related]
16. A COL1A1 Sp1 binding site polymorphism predisposes to osteoporotic fracture by affecting bone density and quality.
Mann V; Hobson EE; Li B; Stewart TL; Grant SF; Robins SP; Aspden RM; Ralston SH
J Clin Invest; 2001 Apr; 107(7):899-907. PubMed ID: 11285309
[TBL] [Abstract][Full Text] [Related]
17. Prevention of postmenopausal bone loss with exchange for short-term HRT for 1alpha-hydroxycholecalciferol.
Ushiroyama T; Ikeda A; Sakai M; Higashiyama T; Ueki M
Maturitas; 2003 Jun; 45(2):119-27. PubMed ID: 12787970
[TBL] [Abstract][Full Text] [Related]
18. Oestrogen-receptor-alpha gene polymorphism affects response in bone mineral density to oestrogen in post-menopausal women.
Ongphiphadhanakul B; Chanprasertyothin S; Payatikul P; Tung SS; Piaseu N; Chailurkit L; Chansirikarn S; Puavilai G; Rajatanavin R
Clin Endocrinol (Oxf); 2000 May; 52(5):581-5. PubMed ID: 10792337
[TBL] [Abstract][Full Text] [Related]
19. Peripheral quantitative computed tomography (pQCT) is useful for monitoring bone mineral density of the patients who receive hormone replacement therapy.
Sawada K; Morishige K; Ohmichi M; Nishio Y; Yamamoto T; Hayakawa J; Mabuchi S; Isobe A; Sasaki H; Sakata M; Tasaka K; Murata Y
Maturitas; 2007 Apr; 56(4):343-9. PubMed ID: 17010541
[TBL] [Abstract][Full Text] [Related]
20. The COL1A1 SP1 polymorphism is associated with lower bone mineral density in patients treated with valproic acid.
Villegas-Martínez I; de-Miguel-Elízaga I; Carrasco-Torres R; Marras C; Canteras-Jordana M; Yedra-Guzmán MJ; Martínez-Villanueva M; Tortosa-Conesa D; Martín-Fernández J
Pharmacogenet Genomics; 2016 Mar; 26(3):126-32. PubMed ID: 26727275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
